Resources

Tobacco Control Act Substantial Equivalence Rebuttal Is Focus of New FDLI Food and Drug Law Policy Forum

Posted on April 2013 by Michael Levin-Epstein

read more

Adverse Event Reporting and Distinct Naming of Biosimilars Is Focus of New FDLI Food and Drug Law Policy Forum

Posted on March 2013 by Michael Levin-Epstein

read more

Prohibition on Use of Chimpanzees for Biomedical Research Is Focus of New FDLI Food and Drug Law Policy Forum

Posted on March 2013 by Michael Levin-Epstein

read more

Implementing Physician Payment Sunshine Act Is Focus of New FDLI Food and Drug Law Policy Forum

Posted on February 2013 by Michael Levin-Epstein

read more

Consequences of Landmark Second Circuit Decision in United States v. Caronia Is Focus of New FDLI Food and Drug Law Policy Forum

Posted on February 2013 by Michael Levin-Epstein

read more

Unique Names for All Biologics and Biosimilars Rebuttal Is Focus of New FDLI Food and Drug Law Policy Forum

Posted on January 2013 by Michael Levin-Epstein

read more

Unique Names for All Biologics and Biosimilars Is Focus of New FDLI Food and Drug Law Policy Forum

Posted on November 2012 by Michael Levin-Epstein

read more

Punishing Unlawful Prescription Drug Promotion Is Focus of New FDLI Food and Drug Law Policy Forum

Posted on October 2012 by Michael Levin-Epstein

read more

DIA and FDLI Collaborate in Conference to Examine User Fees

Posted on August 2012 by Michael Levin-Epstein

read more

Food and Drug Law Institute To Hold Conference on U.S.-Brazil Food and Drug Law

Posted on August 2012 by MIchael Levin-Epstein

read more

Resources

Products & Services